Institutional investors purchased a net $2.6 million shares of DNDNQ during the quarter ended September 2014 and now own 21.36% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POINT72 ASSET MANAGEMENT LP Bought 3.0 Million shares of Dendreon Corp
GOLDMAN SACHS & CO. (PRIVATE BAN... Bought 1.6 Million shares of Dendreon Corp
THE VANGUARD GROUP, INC. Bought 1.5 Million shares of Dendreon Corp